Advanced medical imaging and diagnostic solutions tailored for Jakarta, Surabaya, and Medan medical centers.
As the largest economy in Southeast Asia, Indonesia is undergoing a paradigm shift in healthcare through the "Indonesia Health Transformation Pillars 2021-2024". Oncology has emerged as a top priority due to the rising incidence of cancer cases across the archipelago. Molecular diagnostic systems are no longer a luxury but a fundamental necessity for Precision Medicine and early intervention.
The Ministry of Health (Kemenkes) is actively promoting the localization of medical technology and the adoption of advanced genomic sequencing. For hospitals in Jakarta, Surabaya, and Bandung, the demand for Oncology Molecular Diagnostic Systems—including PCR platforms, Next-Generation Sequencing (NGS), and automated nucleic acid extractors—is surging. Shenzhen BioX Medical Co., Ltd. stands as a premier exporter, bridging the gap between China’s Industry 4.0 manufacturing prowess and Indonesia’s urgent clinical needs.
Navigating BPOM regulations and TKDN (Local Content Requirements) to ensure seamless importation for Indonesian distributors.
High-sensitivity molecular assays designed to detect oncogenic mutations (EGFR, KRAS, BRAF) prevalent in Asian populations.
Specialized cold-chain logistics and robust supply chain management to serve even the remote regions of Kalimantan and Papua.
The roadmap for Indonesian oncology diagnostics involves moving from traditional biopsy to Liquid Biopsy and Multi-Omics integration. Current trends show a significant shift toward:
A Global Leader in Molecular Diagnostic Engineering and Innovation
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
We provide extensive documentation support for Indonesian AKL registration. Our technical teams offer virtual and on-site training for lab technicians across West and East Java, ensuring that oncology diagnostic platforms are operated with maximum precision.
Our Shenzhen-based Smart Factory utilizes AI-driven quality inspection and automated assembly lines. This ensures that every molecular diagnostic system exported to Indonesia meets the highest standards of Analytical Accuracy and Operational Reliability while remaining cost-competitive.
Understanding the unique needs of Indonesian diagnostic brands, we offer flexible OEM services. From UI localization in Bahasa Indonesia to hardware modifications for specific environmental conditions (high humidity/temperature), we are the partner of choice for local medical device companies.
Retaining our complete range of diagnostic and industrial diagnostic support systems.
A modern hospital in Indonesia requires more than just clinical tools; it requires a stable infrastructure. Our Transformer Diagnostic Systems and Voltage Test Systems play a critical role in maintaining the power stability required for sensitive molecular diagnostic equipment. Ensuring that lab freezers and PCR machines have uninterrupted, clean power is vital for the integrity of oncological samples.
Shenzhen BioX Medical Co., Ltd. is committed to advancing modern laboratory technologies. We focus on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, our company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine, with a special focus on the thriving Indonesia market.
Whether you are a medical equipment distributor in Jakarta or a clinical researcher in South Sulawesi, our oncology molecular diagnostic systems offer the precision and durability required for the next decade of medical excellence.
BioX Medical
